Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Naturopath, Regulatory Expert MacKay Returns To DC As CHPA’s Supplement Industry Strategy Chief

Oct 08 2021

• By Eileen Francis

• Source: Alamy

Related Content

Compiling Pre-DSHEA Ingredient List Relies On Bridging FDA-Industry Gap

Oct 04 2017

Wellness Industry News: MacKay Leaving CRN; Another Life-Line Recall, Ginkgo Bioworks' Second Startup, More

Mar 11 2019

FDA's CBD Puzzle: 'Criminals' Continue Or Prohibition Ends And Research Grows

Jun 04 2019

Schumer Includes Cannabinoid Pathway For Supplements In Cannabis Legalization Draft Bill

Jul 14 2021

NDI Notifications For CBD ‘Excluded’ On Arrival But US FDA Still Explains Where Safety Evidence Fails

Aug 11 2021

Additional Topics

International United States US States Dietary Supplements Lobbying Executive Changes Politics Advertising, Marketing & Sales Business Strategies Commercial Compliance Cannabidiol CBD Consumer FDA Manufacturing OTC Drugs Policy Regulation

More from Leadership

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window